Almotriptan use in specific populations

Almotriptan
AXERT® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Almotriptan
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]

Use in Specific Populations

• Pregnancy: based on animal data, may cause fetal harm
• Nursing mothers: use Almotriptan with caution
• Pediatric use: Almotriptan has not been studied in children under 12 years
• Geriatric use: insufficient safety and efficacy data; use with caution, usually starting with the 6.25 mg dose
• Hepatic impairment: use single 6.25 mg tablet as a starting dose; maximum daily dose 12.5 mg
• Severe renal impairment: use single 6.25 mg tablet as a starting dose; maximum daily dose 12.5 mg